Johnson & Johnson At ASCO Highlights Long Term Data From Multiple Myeloma Drug, Shows Sustained Deep, Durable Responses In Pretreated Patients

0.68 Johnson & Johnson At ASCO Highlights Long Term Data From Multiple Myeloma Drug, Shows Sustained Deep, Durable Responses In Pretreated Patients

Friss hírek egy helyen.

bulvárhírek

gazdasági hírek

autós hírek

életmód hírek

sporthírek

<< vissza

Johnson & Johnson At ASCO Highlights Long Term Data From Multiple Myeloma Drug, Shows Sustained Deep, Durable Responses In Pretreated Patients
Dátum: 2024-06-03 [news.yahoo.com]

A TELJES HÍR ELOLVASÁSA >>